UPMC Physicians and Researchers Present at the ACR/ARP 2019 Annual Meeting

October 29, 2019 UPMC and the Division of Rheumatology and Clinical Immunology physicians and researchers will be well-represented at the American College of Rheumatology and Association of Rheumatology Professionals (ACR/ ARP) 2019 Annual Meeting from November 8 – 13 in Atlanta, GA. 

The event brings together more than 16,000 rheumatology experts across the globe. With more than 450 sessions, the meeting provides boundless opportunities for professional development, networking, and access to the latest rheumatology research and clinical applications.

Following is a list of courses, posters, and presentations to be delivered by physicians and researchers from UPMC.

Sunday, Nov. 10

An Incomplete but Functional Categorization of Monogenic Autoinflammation
8:30 – 9 a.m.
Scott Canna, MD 

Contraception and Fertility
9 – 11 a.m.
Mehret Birru Talabi, MD, PhD 

Pre-Rheumatoid Arthritis Diagnosis Prevalence of Commercial CCP Antibody Positivity Increases over Time with Strong Agreement Between Commercial Assays and Positivity Is Predicative of Developing Rheumatoid Arthritis Within 3 Years
9 – 11 a.m.
Steven Taylor, MD

Genetic Signatures Support Inflammation Driven Fibrosis in Localized Scleroderma
9 – 11 a.m.
Christina Schutt, DO 

The Transcription Factor STAT3 Regulates Pathogenic Th17 Responses in Autoimmune Disease via Noncanonical Roles
12:45 – 2:15 p.m.
Catherine Poholek, MD, PhD 

Myopathy: Issues in Diagnosis & Treatment
12:45 – 2:15 p.m.
Chester Oddis, MD 

Management of Difficult Raynaud's & Digital Ischemia
3:30 – 4 p.m.
Thomas Medsger Jr, MD 

Exhausted T Cells in Lupus Nephritis
1 – 2 p.m.
Jeremy Tilstra, MD, PhD 

Macrophage Activation Syndrome & ILD: A New Epidemic
3:45 – 4 p.m.
Scott Canna, MD 

The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud Phenomenon in Early Diffuse Scleroderma: Results of the "Tamer"' Study
3:45 – 4 p.m.
Robyn Domsic, MD, MPH 

Limitations of a Biomedical Model in Rheumatic Diseases
5:15 – 5:30 p.m.
Terence Starz, MD

B Cell-specific MyD88 Regulates Pathology After Disease Onset in Murine Lupus
5:15 – 5:30 p.m.
Jeremy Tilstra, MD, PhD 

Multiplex Serum Analysis Identifies Potential Biomarkers of Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome, and Associated Pulmonary Alveolar Proteinosis: Evidence for Independently-regulated Hyperinflammatory and Eosinophilic Inflammation
5:15- 5:30 p.m.
Scott Canna, MD

Monday, Nov. 11

Myopathy: Issues in Diagnosis & Treatment
12:45 – 2:15 p.m.
Chester Oddis, MD 

Management of Difficult Raynaud's & Digital Ischemia
1 – 2 PM
Thomas Medsger Jr, MD 

Veterans Affairs
1 – 2 p.m.
John S. Richards, MBBS 

Takayasu's Arteritis
5 – 5:30 p.m.
Amr Sawalha, MD

Does Everyone Need Malignancy Screening in Myositis?
5 – 5:30 p.m.
Rohit Aggarwal, MD 

Tuesday, Nov. 12

The Inflammasome & Beyond
7:30- 8:30 a.m.
Scott Canna, MD 

Pediatric Localized Scleroderma (Morphea): Cutaneous & Extra-Cutaneous Manifestations
7:45 – 9:15 a.m.
Kathryn Torok, MD

Perspectives About Contraception Among Reproductive-Aged Women with Rheumatic Diseases
Perspectives of Female Patients with Rheumatic Diseases Regarding Pregnancy Planning with Rheumatologists
9 – 11 a.m.
Mehret Birru Talabi, MD, PhD 

Toward Cardiovascular Risk Stratification in Rheumatoid Arthritis: Use of Regression Tree Analyses to Evaluate Impact of Serum Biomarkers and Cardiovascular Risk Factors on Carotid Intima Media Thickness
9 – 11 AM
Kimberly Liang, MD 

Comparison Between Fibromyalgia and Neuropathic Pain in Patients with Established Rheumatoid Arthritis
9 – 11 a.m.
Yong Gil Hwang, MD

Musculoskeletal Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy: Single Center Experience
9 – 11 a.m.
Didem Saygin, MD 

Associations Between Antibodies to the Angiotensin II Type 1 Receptor and Endothelian-1 Type a Receptor and the Incidence of Vascular Complications in Early Diffuse Systemic Sclerosis
9 – 11 a.m.
Kendall Downer 

Panhypopituitarism in a young man with cancer
9 – 11 a.m.
Daniel Glaser, MD 

Additional Tools to Evaluate Disease Status
11:30 – 12 p.m.
Kathryn Torok, MD 

Takayasu Arteritis Associated Risk Locus in IL6 Represses the Anti-inflammatory Gene GPNMB Through Chromatin Looping and Recruiting MEF2-HDAC Complex
3 – 3:15 p.m.
Amr Sawalha, MD 

Reliability, Validity and Responsiveness of PROMIS PF-20 in Patients with Inflammatory Myopathy
4:30 – 4:45 p.m.
Didem Saygin, MD

Wednesday, Nov. 13

The Right Patients for Success in Telehealth
11 – 11:30 a.m.
Christine Peoples, MD

Awards

Master of the ACR
Chet Oddis, MD

ACR Henry Kunkel Young Investigator Award
Amr Sawalha, MD

Robert Wood Johnson Harold Amos Medical Faculty Development Award
Mehret Birru-Talabi, MD, PhD

Annual Cocktail Reception

Additionally, Larry W. Moreland, MD, Chief, Division of Rheumatology and Clinical Immunology, will host a cocktail reception on Sunday, Nov. 10 from 7 to 9 p.m. at Legacy Test Kitchen. For more information and to RSVP for the event, please click here.